Since paraproteinemia associated with hematological malignancies may influence the BNP levels, we divided the cancer patients into those with hematological cancers (21 patients) and those with solid tumors (59 patients). The gene discussed is NPPB; the disease is hematopoietic and lymphoid cell neoplasm.